Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

EMINASE 30 UNITS 30 UNIT / 5 ML

ANISTREPLASE : 30 UNIT / 5 ML · DIN 02229390 · WELLSPRING PHARMACEUTICAL CANADA CORP

Health Canada status: CANCELLED POST MARKET

What is EMINASE 30 UNITS?

EMINASE 30 UNITS 30 UNIT / 5 ML contains ANISTREPLASE : 30 UNIT / 5 ML. It is listed in the Health Canada Drug Product Database under DIN 02229390, held by WELLSPRING PHARMACEUTICAL CANADA CORP, supplied as POWDER FOR SOLUTION for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 23-Feb-2009. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

Product details and regulatory record

DIN02229390
Brand nameEMINASE 30 UNITS
Generic / active ingredientANISTREPLASE : 30 UNIT / 5 ML
ManufacturerWELLSPRING PHARMACEUTICAL CANADA CORP
Strength30 UNIT / 5 ML
Dosage formPOWDER FOR SOLUTION
Route of administrationINTRAVENOUS
ScheduleSchedule D
ATC codeB01AD03 ANISTREPLASE
AHFS class20:12.20
BiosimilarNo
Health Canada statusCANCELLED POST MARKET
Status date23-Feb-2009
Original market date1997-12-15 00:00:00

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for EMINASE 30 UNITS

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for EMINASE 30 UNITS

Health Canada Drug Product Database (DPD), DIN 02229390. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.